| NDC Code | 83027-0022-1 |
|---|
| Package Description | 60 mL in 1 BOTTLE, SPRAY (83027-0022-1) |
|---|
| Product NDC | 83027-0022 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Fatigue Formula |
|---|
| Non-Proprietary Name | Medulla Ossis Suis, Spleen (bovine), Thymus (bovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-bar Virus Nosode |
|---|
| Dosage Form | SPRAY |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20230313 |
|---|
| End Marketing Date | 20280802 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Nutritional Specialties, Inc. |
|---|
| Substance Name | BOS TAURUS SPLEEN; BOS TAURUS THYMUS; HUMAN BREAST TUMOR CELL; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); STREPTOCOCCUS VIRIDANS GROUP; SUS SCROFA BONE MARROW; TOXOPLASMA GONDII |
|---|
| Strength | 6; 6; 16; 16; 16; 16; 16; 16; 16; 16; 6; 16 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|